Hide
Show all
Topical Gadobutrol Application Causes Fluorescence Intensity Change in RFP-expressing Tumor-Bearing Mice
Victoria V. Zherdeva
(Login required)
Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow, Russian Federation
Paper #3398 received 28 Dec 2020; revised manuscript received 28 Jan 2021; accepted for publication 29 Jan 2021; published online 27 Mar 2021.
DOI: 10.18287/JBPE21.07.020301
Abstract
Optical clearing (OC) allows one to observe tissue structures and metabolic processes occurring in opaque tissues at the depths significantly exceeding the depths that can be reached without OC. Recently, we have shown that gadobutrol is a promising agent for OC of tissues in vivo. The aim of this study was to investigate the effect of time-dependence optical clearing caused by gadobutrol on intensity of fluorescent protein constitutively expressed in subcutaneous tumors in vivo. The measurements were performed in nu/nu mice bearing HEp-2 tumors expressing the red fluorescent protein TagRFP. Gadobutrol was used directly at concentrations 1.0 M aqueous solution or as a 0.7 M aqueous solution containing 5% dimethyl sulfoxide (DMSO). Gadobutrol was applied topically onto the skin above the tumors for 15 min. Tissue fluorescence was measured by using in vivo planar imaging technique. It was shown that the fluorescence intensity of tumors increased by 1.1–1.5 times in different animals under the influence of gadobutrol. The increase in intensity was more pronounced in the case of 0.7 M gadobutrol supplemented with DMSO. Apparently, the observed difference of penetration depths was due to the presence of DMSO in 0.7 M gadobutrol mixture.
Keywords
Full Text:
PDFReferences
1. A. Zelmer, T. H. Ward, “Noninvasive fluorescence imaging of small animals,” Journal of microscopy 252(1), 8–15 (2013).
2. N. Stemmer, J. Mehnert, J. Steinbrink, and A. Wunder, “Noninvasive fluorescence imaging in animal models of stroke,” Current Medicinal Chemistry 19(28), 4786–4793 (2012).
3. J. P. Miller, C. Egbulefu, J. L. Prior, M. Zhou, and S. Achilefu, “Gradient-Based Algorithm for Determining Tumor Volumes in Small Animals Using Planar Fluorescence Imaging Platform,” Tomography 2(1), 17–25 (2016).
4. I. G. Meerovich, N. I. Kazachkina, and A. P. Savitsky, “Investigation of the effect of photosensitizer Tiosense on the tumor model melKor-TurboRFP expressed red fluorescent protein,” Russian Journal of General Chemistry 85(1), 274–279 (2015).
5. E. V. Sanarova, A. V. Lantsova, A. P. Polozkova, O. L. Orlova, I. G. Meerovich, L. M. Borisova, M. P. Kiseleva, Z. S. Smirnova, N. Yu. Kul’bachevskaya, O. I. Konyaeva, and N. A. Oborotova, “Effectiveness of liposomal system of delivery of hydrophobic antineoplastic Thiosens photosensitizer,” Nanotechnologies in Russia 10(5–6), 492-500 (2015).
6. A. I. Gavrina, M. V. Shirmanova, N. A. Aksenova, D. V. Yuzhakova, L. B. Snopova, A. B. Solovieva, P. S. Тimashev, V. V. Dudenkova, and E. V. Zagaynova, “Photodynamic therapy of mouse tumor model using chlorin e6- polyvinyl alcohol complex,” Journal of Photochemistry and Photobiology B: Biology 178, 614–622 (2018).
7. Y. Guan, T. Sun, J. Ding, and Z. Xie, “Robust organic nanoparticles for noninvasive long-term fluorescence imaging,” Journal of Materials Chemistry B 7(44), 6879–6889 (2019).
8. Y. F. Loginova, Y. F. Loginova, S. V. Dezhurov, V. V. Zherdeva, N. I. Kazachkina, M. S. Wakstein, and A. P. Savitsky, “Biodistribution and stability of CdSe core quantum dots in mouse digestive tract following per os administration: advantages of double polymer/silica coated nanocrystals,” Biochemical and Biophysical Research Communications 419(1), 54–59 (2012).
9. F. Stuker, J. Ripoll, and M. Rudin, “Fluorescence Molecular Tomography: Principles and Potential for Pharmaceutical Research,” Pharmaceutics 3(2), 229–274 (2011).
10. D. Zhu, K. V. Larin, Q. Luo, and V. V. Tuchin, “Recent progress in tissue optical clearing,” Laser & Photonics Reviews 7(5), 732–757 (2013).
11. D. S. Richardson, J. W. Lichtman, “Clarifying tissue clearing,” Cell 162(2), 246–257 (2015).
12. P. Matryba, L. Kaczmarek, and J. Gołab, “Advances in ex situ tissue optical clearing,” Laser & Photonics Reviews 13(8), 1800292 (2019).
13. I. Costantini, R. Cicchi, L. Silvestri, F. Vanzi, and F. S. Pavone, “In-vivo and ex-vivo optical clearing methods for biological tissues: Review,” Biomedical Optics Express 10(10), 5251–5267 (2019).
14. A. Yu. Sdobnov, J. Lademann, M. E. Darvin, and V. V. Tuchin, “Methods for Optical Skin Clearing in Molecular Optical Imaging in Dermatology,” Biochemistry 84(Suppl 1), S144–S158 (2019).
15. D. K. Tuchina, I. G. Meerovich, O. A. Sindeeva, V. V. Zherdeva, A. P. Savitsky, A. A. Bogdanov Jr., and V. V. Tuchin, “Magnetic resonance contrast agents in optical clearing: Prospects for multimodal tissue imaging,” Journal of Biophotonics 13(11), e201960249 (2020).
16. Q. Xie, N. Zeng, Y. Huang, V. V. Tuchin, and H. Ma, “Study on the tissue clearing process using different agents by Mueller matrix microscope,” Biomedical Optics Express 10(7), 3269 (2019).
17. A. A. Bogdanov Jr., N. I. Kazachkina, V. V. Zherdeva, I. G. Meerovich, D. K. Tuchina, I. D. Solovyev, A. P. Savitsky, and V. V. Tuchin, “Magnetic resonance imaging study of diamagnetic and paramagnetic agents for optical clearing of tumor-specific fluorescent signal in vivo,” Chapter 25 in Tissue optical clearing: new prospects in optical imaging, D. Zhu, E. Genina, and V. Tuchin (Eds.), CRC Press, Boca Raton, FL (2021) [In press].
18. D. K. Tuchina, I. G. Meerovich, O. A. Sindeeva, V. V. Zherdeva, N. I. Kazachkina, I. D. Solov'ev, A. P. Savitsky, A. A. Bogdanov Jr., and V. V. Tuchin, “Prospects for multimodal imaging of biological tissues using fluorescence imaging,” Quantum Electronics 51(2), 104–117 (2021).
19. K. Bai, J. Katz, “On the refractive index of sodium iodide solutions for index matching in PIV,” Experiments in Fluids 55, 1704 (2014).
© 2014-2025 Authors
Public Media Certificate (RUS). 12+